Page last updated: 2024-08-25

clarithromycin and Pneumonia, Bacterial

clarithromycin has been researched along with Pneumonia, Bacterial in 95 studies

Research

Studies (95)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	20 (21.05)	18.2507
2000's	48 (50.53)	29.6817
2010's	21 (22.11)	24.3611
2020's	6 (6.32)	2.80

Authors

Authors	Studies
Hammerschlag, MR; Kohlhoff, SA; Parker, C; Roblin, PM	1
Al-Salloum, J; Gillani, SW; Gulam, SM; Mahmood, RK	1
Aljabri, A; Almehmadi, M; Alqahtani, N; Alraddadi, B; Aseeri, MA; Assabban, Z; Bahobail, F; Botaish, A; Eljaaly, K; Hashim, A; Thabit, AK; Torres, A	1
Adami, ME; Alexiou, N; Giamarellos-Bourboulis, EJ; Gogos, C; Halvatzis, S; Kosmas, V; Koutoukas, P; Kyprianou, A; Kyprianou, M; Kyriakoudi, A; Kyriazopoulou, E; Lada, M; Makina, A; Niederman, MS; Pavlaki, M; Sinapidis, D; Stefos, A; Velissaris, D	1
Akyüz, S; Aşker, S; Baran, Aİ; Ekin, S; Özgökçe, M; Sünnetçioğlu, A; Turgut, E; Üney, İ; Yildiz, H	1
Fujita, K; Hayakawa, H; Ito, Y; Iwaizumi, E; Kanai, M; Kojima, S; Miwa, S; Ohba, H; Oshima, T; Shirai, M; Suda, T	1
Begbey, A; Guppy, JH; Mohan, C; Webster, S	1
Inoue, Y; Kimura, Y; Kobayashi, T; Kurahara, Y; Minomo, S; Suzuki, K; Tsuji, T; Tsuyuguchi, K; Yoshida, S	1
Adamopoulou, M; Giamarellos-Bourboulis, EJ; Kotanidou, A; Orfanos, SE; Raftogiannis, M; Renieris, G; Routsi, C; Sabracos, L; Strouvalis, I	1
Harvey, E; Varatharaj, A	1
Asteriades, S; Georgalas, I; Nasr, MB; Tranos, P; Vakalis, A	1
Jeong, BH; Jeong, YJ; Kim, HJ; Koh, WJ; Lee, G; Lee, KS; Moon, JW; Woo, S	1
Arnold, C; Bassetti, S; Piso, RJ	1
Caumes, E; de Masson, A; Maillart, E; Meyssonnier, V; Papeix, C; Veziris, N	1
Baraldo, M; Cojutti, P; Livi, U; Pea, F; Tursi, V	1
Hara, A; Harada, T; Ishimatsu, Y; Izumikawa, K; Kakugawa, T; Kohno, S; Kosai, K; Morita, T; Mukae, H; Nakashima, S; Sakamoto, N; Yanagihara, K	1
Astudillo, L; Couture, G; Geniez, C; Pugnet, G; Sailler, L	1
Iida, K; Sasaoka, Y; Tatsumi, M; Tsutsumi, H; Yoto, Y	1
Giguère, S	1
McKinnell, J; Tayek, JA	1
Hashino, S; Ohe, M	1
Baranowski, WJ	1
Barman, TK; Bhadauria, T; Bhateja, P; Bhatnagar, PK; Chakrabarti, A; Das, B; Katoch, R; Kumar, GR; Malhotra, S; Mathur, T; Pandya, M; Rao, M; Rathy, S; Upadhyay, D; Venkataraman, R	1
Bai, N; Cai, Y; Chai, D; Liang, BB; Liu, Y; Wang, R	1
Mikamo, H; Yamagishi, Y	1
Fitting, JW; Greub, G; Jaton, K; Senn, L	1
Cei, M; Mumoli, N	1
Aarnoutse, RE; Boeree, MJ; Daley, CL; Egelund, EF; Heifets, LB; Levin, A; Mouton, JW; Peloquin, CA; Totten, SE; van Ingen, J	1
Baglioni, S; Eslami, A; Todisco, C; Todisco, T	1
Arita, M; Hashimoto, T; Ishida, T; Ito, I; Kishimoto, T; Mishima, M; Osawa, M	1
Duprat-Lomon, I; Lamping, DL; Marquis, P; Marrel, A; Sagnier, PP; Schroter, S	1
Chuah, SK; Gollapudi, S; Iskandar, L; Thadepalli, H	1
Cabré, X; Falguera, M; Ferrer, G; Pérez, J; Ruiz, A; Sacristán, O; Vallverdú, M	1
Cravarezza, P; Donati, P; Franchino, L; Grassi, V; Pozzi, A; Prometti, P; Ravizzola, G; Romanelli, G; Zulli, R	1
Malcolm, C; Marrie, TJ	1
Nagai, H	1
García, E; González, J; Marco, F; Marcos, MA; Martínez, JA; Mensa, J; Sánchez, F; Soriano, A; Torres, A	1
Carbon, C; Dunbar, L; Fogarty, C; Hagberg, L; Pullman, J; van Rensburg, DJ	1
Becker, DL; Chancellor, JV; Drummond, MF; Duprat-Lomon, I; Hux, M; Kubin, R; Sagnier, PP	1
Choudhri, S; Church, D; Grossman, C; Haverstock, D; Herman-Gnjidic, Z; Lode, H; McGivern, J	1
Ninomiya, K	1
Aizawa, H; Fujiki, R; Kawayama, T; Rikimaru, T	1
Aronkyto, T; Chuchalin, AG; Jaaskevi, M; Kahnovskii, I; Kleutgens, K; Lode, H	1
Banevicius, MA; Capitano, B; Geng, Q; Maglio, D; Nicolau, DP; Nightingale, CH	1
Asche, CV; Chang, JR; Lavin, B; Niederman, MS; Nusrat, R; Stewart, J; Sullivan, SD	1
Iutanova, NS	1
Azam, S; Dhakam, S; Kiran, N	1
Beecroft, MD; Herman-Gnjidic, Z; Marrie, TJ	1
González-Granda, D; Labrador, T; Martínez, I; Nieto, A; Querol-Borrás, JM; Querol-Ribelles, JM; Tenías, JM	1
García Vázquez, E; Marcos, MA; Martínez, JA; Mensa, J; Ortega, M; Puig, J; Torres, A	1
Armstrong, EP; Malone, DC; Ramachandran, S; Skrepnek, GH	1
Zar, HJ	1
Bando, M; Ishii, Y; Ohno, S; Sugiyama, Y	1
Lunn, JA; Malik, R; Martin, P; Zaki, S	1
Morovic, M	1
Dean, NC; Hadlock, C; Sperry, P; Suchyta, MS; Wikler, M	1
Alvarez, J; Brown-Elliott, BA; Caccitolo, J; Girard, W; Graviss, EA; Griffith, DE; Langsjoen, B; Nelson, K; Pan, X; Shepherd, S; Wallace, RJ; Wilson, R; Zhang, Y	1
Block, SL	1
Barbe, F; García, M; Pifarre Teixido, R; Vicente de Vera, C	1
Boswinkel, M; Sloet van Oldruitenborgh-Oosterbaan, MM	1
Brumble, L; Garland, JL; Johnson, MM; Khoor, A; Roy, A; Waller, EA	1
Ichihara, E; Kanehiro, A; Kiura, K; Kubo, T; Miyahara, N; Tabata, M; Takigawa, N; Tanimoto, M; Tanimoto, Y	1
Decramer, M; Martin, M; Moore, L; Quilici, S; Simoens, S	1
Delia, S; Iona, E; Mascellino, MT; Mastroianni, CM; Ponzo, R	1
Fanti, D; Fraioli, P; Magliano, E; Montanari, G; Montemurro, L; Pozzoli, R; Rizzato, G	1
Fung, CP; Jang, TN; Liu, CY; Wang, FD; Yang, SP	1
Casas, JM; Gómez-Cadiñanos, RA; Oteo, JA; Rosel, L	1
Dalhoff, K; Maass, M	1
Hammerschlag, MR; Montalban, G; Roblin, PM	1
Asnis, DS; Bresciani, AR; Cohn, M	1
Borderas, F; Delgado, J; Gallardo, JA; Leal, M; Lissen, E; Macías, J; Pineda, JA; Sánchez-Quijano, A	1
Block, SL; Harris, J; Kolokathis, A; Tarlow, MJ	1
Huyghens, L; Lauwers, S; Meysman, M; Monsieur, I; Vincken, W	1
Baraia-Etxaburu, J; Cisterna, R; Malero, P; Muñoz, J; Santamaría, JM; Teira, R; Unzaga, MJ	1
de Torrenté, A; Genné, D; Humair, L; Janin-Jaquat, B; Siegrist, HH	1
Klein, JO	1
Burman, WJ; Dunne, EF; Wilson, ML	1
Cadwgan, AM; Laing, RB; MacKenzie, AR	1
Muller, O; O'Doherty, B	1
Ramirez, J; Talbot, GH; Townsend, L; Unowsky, J; Zhang, H	1
Higashiyama, Y; Kohno, S; Maesaki, S; Miyazaki, Y; Tashiro, T; Tomiyama, Y; Tomono, K; Yong, B	1
Belda, A; Gonzalvo, F; Martínez-Moragón, E; Pascual, JM; Ripollés, F; Rovira, E	1
Churchyard, GA; Dylewski, JS; Hagberg, L; Moola, S; Sedani, S; Staley, H	1
Banevicius, MA; Bui, KQ; Nicolau, DP; Nightingale, CH; Quintiliani, R	1
Bayliff, CD; Bombassaro, AM; McCormack, DG; Nolan, T; Offman, E; Varin, F	1
Hammerschlag, MR; Roblin, PM	1
Hammerschlag, MR	1
Hamada, H; Hiwada, K; Kohno, N; Kondo, K; Yokoyama, A	1
Koizumi, T; Kubo, K; Yaguchi, Y; Yamauchi, K; Yamazaki, Y; Yanagisawa, H	1
Kroegel, C; Mock, B; Rödel, J	1
Horikawa, S; Ikeue, T; Maekawa, N; Nishiyama, H; Sugita, T; Suzuki, Y; Ueshima, K; Watanabe, S	1
Hanaoka, T; Katsuragi, N; Konno, H; Nakajima, Y; Shiraishi, Y; Takasuna, K	1
Báñez, F; Biechy, M; Gálvez, E; Salgueró, E	1
Bobbaers, H; Collins, O; Finch, R; Hoeffken, G; Izquierdo, JL; Kubin, R; McGivern, J; Nikolaides, P; Ogundare, F; Raz, R; Schürmann, D; Zuck, P	1
Huth, RG; Jahn, B; Kamin, W; Knuf, M; Meyer, HG; Trübel, HK	1

Reviews

11 review(s) available for clarithromycin and Pneumonia, Bacterial

Article	Year
Comparative efficacy of azithromycin versus clarithromycin in combination with beta-lactams to treat community-acquired pneumonia in hospitalized patients: a systematic review. The Journal of international medical research, 2021, Volume: 49, Issue:10 Topics: Adult; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Clarithromycin; Community-Acquired Infections; Humans; Pneumonia, Bacterial	2021
Systematic review and meta-analysis of the safety of erythromycin compared to clarithromycin in adults and adolescents with pneumonia. Journal of chemotherapy (Florence, Italy), 2020, Volume: 32, Issue:1 Topics: Adolescent; Adult; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Erythromycin; Female; Humans; Male; Pneumonia, Bacterial	2020
Treatment of Infections Caused by Rhodococcus equi. The Veterinary clinics of North America. Equine practice, 2017, Volume: 33, Issue:1 Topics: Actinomycetales Infections; Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Horse Diseases; Horses; Pneumonia, Bacterial; Rhodococcus equi; Rifampin	2017
Effectiveness and safety of macrolides in cystic fibrosis patients: a meta-analysis and systematic review. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:5 Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cystic Fibrosis; Humans; Lung; Macrolides; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Respiratory Function Tests; Treatment Outcome	2011
[Combination therapy with macrolides for pneumonia]. The Japanese journal of antibiotics, 2011, Volume: 64, Issue:3 Topics: Aged; Anti-Bacterial Agents; Bacteria; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Humans; Macrolides; Male; Pneumonia, Bacterial; Practice Guidelines as Topic	2011
[Nontuberculous mycobacteriosis]. Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 2 Topics: Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Pneumonia, Bacterial; Prognosis; Rifampin; Streptomycin	2003
Telithromycin in the treatment of community-acquired pneumonia: a pooled analysis. Respiratory medicine, 2003, Volume: 97, Issue:6 Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Double-Blind Method; Fluoroquinolones; Humans; Ketolides; Macrolides; Naphthyridines; Penicillins; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Treatment Outcome	2003
Neonatal chlamydial infections: prevention and treatment. Paediatric drugs, 2005, Volume: 7, Issue:2 Topics: Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Clarithromycin; Humans; Infant, Newborn; Ophthalmia Neonatorum; Pneumonia, Bacterial; Roxithromycin	2005
[Diagnosis and therapy of Rhodococcus equi infection in the horse]. Tijdschrift voor diergeneeskunde, 2006, Sep-01, Volume: 131, Issue:17 Topics: Actinomycetales Infections; Animals; Animals, Newborn; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Therapy, Combination; Erythromycin; Horse Diseases; Horses; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Treatment Outcome	2006
Future indications for macrolides. The Pediatric infectious disease journal, 1997, Volume: 16, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Community-Acquired Infections; Helicobacter Infections; Humans; Malaria; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial	1997
Streptomyces pneumonia in a patient with human immunodeficiency virus infection: case report and review of the literature on invasive streptomyces infections. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 27, Issue:1 Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Humans; Male; Pneumonia, Bacterial; Streptomyces	1998

Trials

27 trial(s) available for clarithromycin and Pneumonia, Bacterial

Article	Year
Early increase of VEGF-A is associated with resolution of ventilator-associated pneumonia: Clinical and experimental evidence. Respirology (Carlton, Vic.), 2018, Volume: 23, Issue:10 Topics: Animals; Anti-Bacterial Agents; APACHE; Biomarkers; Bronchoalveolar Lavage Fluid; Clarithromycin; Double-Blind Method; Humans; Interferon-gamma; Interleukin-1beta; Mice; Peroxidase; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Time Factors; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A	2018
An open, comparative pilot study of thiamphenicol glycinate hydrochloride vs clarithromycin in the treatment of acute lower respiratory tract infections due to Chlamydia pneumoniae. Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:3 Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Drug Administration Schedule; Female; Humans; Immunoglobulins; Male; Middle Aged; Pilot Projects; Pneumonia, Bacterial; Radiography; Thiamphenicol; Treatment Outcome	2002
The community-acquired pneumonia symptom questionnaire: a new, patient-based outcome measure to evaluate symptoms in patients with community-acquired pneumonia. Chest, 2002, Volume: 122, Issue:3 Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Aza Compounds; Clarithromycin; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Outcome Assessment, Health Care; Pneumonia, Bacterial; Psychometrics; Quality Assurance, Health Care; Quinolines; Surveys and Questionnaires	2002
[Community-acquired pneumonia: usefulness of clinical presentation in the selection of antibiotic treatment]. Medicina clinica, 2002, Nov-16, Volume: 119, Issue:17 Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Community-Acquired Infections; Female; Hospitalization; Humans; Length of Stay; Levofloxacin; Male; Middle Aged; Ofloxacin; Penicillins; Pneumonia, Bacterial; Treatment Outcome	2002
Carbapenems in the treatment of severe community-acquired pneumonia in hospitalized elderly patients: a comparative study against standard therapy. Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:6 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Community-Acquired Infections; Costs and Cost Analysis; Drug Combinations; Drug Costs; Drug Therapy, Combination; Female; Hospitalization; Humans; Imipenem; Male; Meropenem; Pneumonia, Bacterial; Prospective Studies; Thienamycins; Treatment Outcome	2002
Is azithromycin the first-choice macrolide for treatment of community-acquired pneumonia? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, May-15, Volume: 36, Issue:10 Topics: Adult; Aged; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Community-Acquired Infections; Follow-Up Studies; Humans; Length of Stay; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome	2003
Sequential IV/PO moxifloxacin treatment of patients with severe community-acquired pneumonia. Respiratory medicine, 2003, Volume: 97, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aza Compounds; Clarithromycin; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Naphthyridines; Pneumonia, Bacterial; Quinolines; Retrospective Studies; Treatment Outcome	2003
[Beneficial effects of macrolide antibiotics on children with influenza]. The Japanese journal of antibiotics, 2003, Volume: 56 Suppl A Topics: Adolescent; Bacteria; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Infant; Influenza, Human; Male; Pharynx; Pneumonia, Bacterial; Treatment Outcome	2003
[Clinical efficacy of oral clarithromycin monotherapy in patients with mild or moderate community-acquired pneumonia]. The Japanese journal of antibiotics, 2003, Volume: 56, Issue:6 Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Female; Haemophilus influenzae; Humans; Male; Middle Aged; Mycoplasma pneumoniae; Pneumonia, Bacterial; Severity of Illness Index; Streptococcus pneumoniae; Treatment Outcome	2003
A randomised, double-blind, double-dummy comparative study of gatifloxacin with clarithromycin in the treatment of community-acquired pneumonia. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2004, Volume: 10, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Double-Blind Method; Drug Resistance, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome	2004
Hospitalization rates among patients with community-acquired pneumonia treated with telithromycin vs clarithromycin: results from two randomized, double-blind, clinical trials. Current medical research and opinion, 2004, Volume: 20, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Double-Blind Method; Female; Hospitalization; Humans; Ketolides; Macrolides; Male; Middle Aged; Pneumonia, Bacterial	2004
[Clinical efficacy of clarithromycin delayed release dosage form in the treatment of community-acquired pneumonia]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2004, Volume: 49, Issue:3 Topics: Adolescent; Adult; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Delayed-Action Preparations; Female; Haemophilus influenzae; Humans; Male; Middle Aged; Pneumonia, Bacterial; Staphylococcus aureus; Streptococcus pneumoniae	2004
Resolution of symptoms in patients with community-acquired pneumonia treated on an ambulatory basis. The Journal of infection, 2004, Volume: 49, Issue:4 Topics: Adult; Ambulatory Care; Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Community-Acquired Infections; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Pneumonia, Bacterial; Prospective Studies; Quinolines; Severity of Illness Index; Treatment Outcome	2004
Levofloxacin versus ceftriaxone plus clarithromycin in the treatment of adults with community-acquired pneumonia requiring hospitalization. International journal of antimicrobial agents, 2005, Volume: 25, Issue:1 Topics: Aged; Anti-Bacterial Agents; Ceftriaxone; Clarithromycin; Cohort Studies; Community-Acquired Infections; Drug Therapy, Combination; Female; Hospitalization; Humans; Levofloxacin; Male; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome	2005
Q Fever pneumonia: are clarithromycin and moxifloxacin alternative treatments only? The American journal of tropical medicine and hygiene, 2005, Volume: 73, Issue:5 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Child; Clarithromycin; Coxiella burnetii; Doxycycline; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Pneumonia, Bacterial; Q Fever; Quinolines; Treatment Outcome	2005
Comparing gatifloxacin and clarithromycin in pneumonia symptom resolution and process of care. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:4 Topics: Adult; Aged; Anti-Bacterial Agents; Ceftriaxone; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Fluoroquinolones; Gatifloxacin; Humans; Length of Stay; Middle Aged; Pneumonia, Bacterial; Prospective Studies	2006
Comparative tolerability, safety and efficacy of tablet formulations of twice-daily clarithromycin 250 mg versus once-daily extended-release clarithromycin 500 mg in pediatric and adolescent patients. Clinical pediatrics, 2006, Volume: 45, Issue:7 Topics: Adolescent; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Child; Clarithromycin; Drug Administration Schedule; Female; Humans; Male; Pharyngitis; Pneumonia, Bacterial; Sinusitis; Skin Diseases, Bacterial; Streptococcal Infections; Tablets; Treatment Outcome	2006
Efficacy of a three day course of azithromycin in moderately severe community-acquired pneumonia. The European respiratory journal, 1995, Volume: 8, Issue:3 Topics: Adult; Azithromycin; Clarithromycin; Community-Acquired Infections; Drug Administration Schedule; Female; Hospitalization; Humans; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome	1995
A randomized comparative study on the safety and efficacy of clarithromycin and erythromycin in treating community-acquired pneumonia. Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 1995, Volume: 55, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Clarithromycin; Erythromycin; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial	1995
Susceptibilities to clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumonia. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:7 Topics: Child; Child, Preschool; Chlamydia Infections; Chlamydophila pneumoniae; Clarithromycin; Erythromycin; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial	1994
Clarithromycin versus amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1997, Volume: 16, Issue:11 Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies	1997
Randomized, multicentre study of the efficacy and tolerance of azithromycin versus clarithromycin in the treatment of adults with mild to moderate community-acquired pneumonia. Azithromycin Study Group. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:12 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Community-Acquired Infections; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome	1998
Sparfloxacin versus clarithromycin in the treatment of community-acquired pneumonia. Clinical therapeutics, 1999, Volume: 21, Issue:1 Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Community-Acquired Infections; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Pneumonia, Bacterial; Quinolones	1999
Treatment of community-acquired pneumonia in outpatients: randomized study of clarithromycin alone versus clarithromycin and cefuroxime. Respiration; international review of thoracic diseases, 1999, Volume: 66, Issue:5 Topics: Adult; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Male; Pneumonia, Bacterial	1999
A multicenter study of grepafloxacin and clarithromycin in the treatment of patients with community-acquired pneumonia. Chest, 1999, Volume: 116, Issue:4 Topics: Adult; Aged; Anti-Infective Agents; Clarithromycin; Community-Acquired Infections; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Male; Middle Aged; Piperazines; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome	1999
Microbiologic efficacy of moxifloxacin for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae. International journal of antimicrobial agents, 2000, Volume: 15, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Chlamydia Infections; Chlamydophila pneumoniae; Clarithromycin; Community-Acquired Infections; Fluoroquinolones; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Moxifloxacin; Nasopharynx; Pneumonia, Bacterial; Quinolines	2000
Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatment. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:6 Topics: Administration, Oral; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteria; Clarithromycin; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Pneumonia, Bacterial; Quinolines	2002

Other Studies

57 other study(ies) available for clarithromycin and Pneumonia, Bacterial

Article	Year
In vitro activity of CEM-101, a new fluoroketolide antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3 Topics: Adult; Anti-Bacterial Agents; Child; Child, Preschool; Chlamydia Infections; Chlamydia trachomatis; Chlamydophila Infections; Chlamydophila pneumoniae; Female; Humans; Infant; Macrolides; Microbial Sensitivity Tests; Pneumonia, Bacterial; Triazoles	2010
Survival benefit associated with clarithromycin in severe community-acquired pneumonia: A matched comparator study. International journal of antimicrobial agents, 2020, Volume: 55, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Clarithromycin; Cohort Studies; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Macrolides; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome	2020
Delftia acidovorans pneumonia with lung cavities formation. Colombia medica (Cali, Colombia), 2019, Sep-30, Volume: 50, Issue:3 Topics: Anti-Bacterial Agents; Clarithromycin; Delftia acidovorans; Female; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Lung; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Tomography, X-Ray Computed	2019
Macrolide resistant Mycobacterium avium complex pulmonary disease following clarithromycin and ethambutol combination therapy. Respiratory medicine, 2020, Volume: 169 Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Incidence; Japan; Macrolides; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Negative Results; Pneumonia, Bacterial; Rifampin	2020
BMJ case reports, 2020, Dec-31, Volume: 13, Issue:12 Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Comorbidity; Crohn Disease; Enterobacteriaceae Infections; Female; Hafnia alvei; Humans; Immunocompromised Host; Male; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Rare Diseases; Treatment Outcome; Young Adult	2020
Resumption/efficacy and safety of an azithromycin-containing regimen against Mycobacterium avium complex lung disease in patients who experienced adverse effects with a clarithromycin-containing regimen. Respiratory investigation, 2021, Volume: 59, Issue:2 Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial; Retrospective Studies; Treatment Outcome	2021
Round pneumonia. QJM : monthly journal of the Association of Physicians, 2014, Volume: 107, Issue:3 Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clarithromycin; Diagnosis, Differential; Female; Humans; Pneumonia, Bacterial; Tomography, X-Ray Computed	2014
Bilateral diffuse iris atrophy after the use of oral clarithromycin. Cutaneous and ocular toxicology, 2014, Volume: 33, Issue:1 Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Atrophy; Clarithromycin; Female; Humans; Iris; Iris Diseases; Pneumonia, Bacterial	2014
Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans. Annals of the American Thoracic Society, 2013, Volume: 10, Issue:4 Topics: Aged; Anti-Bacterial Agents; Azithromycin; Bronchiectasis; Clarithromycin; Disease Progression; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung; Male; Middle Aged; Multiple Pulmonary Nodules; Multivariate Analysis; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial; Proportional Hazards Models; Retrospective Studies; Rifampin; Tomography, X-Ray Computed	2013
Coverage of atypical pathogens for hospitalised patients with community-acquired pneumonia is not guided by clinical parameters. Swiss medical weekly, 2013, Volume: 143 Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; beta-Lactams; Chlamydial Pneumonia; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Guideline Adherence; Hospitalization; Humans; Immunocompromised Host; Legionnaires' Disease; Macrolides; Male; Middle Aged; Odds Ratio; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Pneumonia, Pneumococcal; Practice Guidelines as Topic; Practice Patterns, Physicians'; Retrospective Studies; Severity of Illness Index	2013
Cavitary pulmonary disease in a patient treated with natalizumab. Presse medicale (Paris, France : 1983), 2014, Volume: 43, Issue:9 Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antitubercular Agents; Clarithromycin; Ethambutol; Female; Humans; Multiple Sclerosis, Relapsing-Remitting; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Natalizumab; Pneumonia, Bacterial	2014
Everolimus overexposure in a heart transplant patient receiving clarithromycin for the treatment of pneumonia. Transplant infectious disease : an official journal of the Transplantation Society, 2015, Volume: 17, Issue:6 Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Interactions; Everolimus; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Pneumonia, Bacterial	2015
Premedication with Clarithromycin Is Effective against Secondary Bacterial Pneumonia during Influenza Virus Infection in a Pulmonary Emphysema Mouse Model. The Journal of pharmacology and experimental therapeutics, 2016, Volume: 358, Issue:3 Topics: Animals; Bacterial Load; Cell Count; Chemokines; Clarithromycin; Coinfection; Disease Models, Animal; Influenza A Virus, H1N1 Subtype; Lung; Mice; Neutrophils; Orthomyxoviridae Infections; Pneumonia, Bacterial; Pulmonary Emphysema; Streptococcus pneumoniae; Survival Analysis; Viral Load	2016
[Second case of serum sickness-like reaction to claritrhomycin]. Presse medicale (Paris, France : 1983), 2016, Volume: 45, Issue:11 Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Drug Therapy, Combination; Female; Humans; Pneumonia, Bacterial; Serum Sickness	2016
Neonatal apnea with Chlamydia pneumoniae infection. Pediatrics international : official journal of the Japan Pediatric Society, 2017, Volume: 59, Issue:1 Topics: Anti-Bacterial Agents; Apnea; Chlamydophila pneumoniae; Clarithromycin; Gestational Age; Humans; Infant, Newborn; Infant, Newborn, Diseases; Male; Oxygen Consumption; Pneumonia, Bacterial; Polymerase Chain Reaction	2017
Short term treatment with clarithromycin resulting in colchicine-induced rhabdomyolysis. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2009, Volume: 15, Issue:6 Topics: Anti-Bacterial Agents; Ceftriaxone; Clarithromycin; Colchicine; Community-Acquired Infections; Doxycycline; Drug Interactions; Gout; Gout Suppressants; Humans; Male; Middle Aged; Pneumonia, Bacterial; Rhabdomyolysis; Treatment Outcome	2009
[Successful treatment with clarithromycin for Mixed phenotype acute leukemia, T/myeloid, NOS]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2010, Volume: 51, Issue:4 Topics: Acute Disease; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Myeloid, Acute; Pneumonia, Bacterial; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone	2010
Clarithromycin-induced hypomania in a child - a case report. Acta psychiatrica Scandinavica, 2010, Volume: 122, Issue:3 Topics: Administration, Oral; Anti-Bacterial Agents; Bipolar Disorder; Child, Preschool; Clarithromycin; Community-Acquired Infections; Humans; Male; Pneumonia, Bacterial	2010
Activity of a novel series of acylides active against community-acquired respiratory pathogens. International journal of antimicrobial agents, 2010, Volume: 36, Issue:2 Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Drug Evaluation, Preclinical; Haemophilus influenzae; Humans; Mice; Microbial Sensitivity Tests; Moraxella catarrhalis; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Time Factors	2010
Does respiratory infection due to Chlamydia pneumoniae still exist? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Volume: 53, Issue:8 Topics: Adolescent; Bacterial Load; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Cough; Diagnosis, Differential; DNA, Bacterial; Female; Humans; Male; Middle Aged; Nasopharynx; Pneumonia, Bacterial; Polymerase Chain Reaction; Respiratory Tract Infections; Sputum	2011
Clinical images: community-acquired pneumonia. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2012, Mar-20, Volume: 184, Issue:5 Topics: Adult; Anti-Bacterial Agents; Chest Pain; Clarithromycin; Community-Acquired Infections; Cough; Humans; Leukocyte Count; Lung; Male; Penicillins; Pneumonia, Bacterial; Radiography; Severity of Illness Index	2012
The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment. American journal of respiratory and critical care medicine, 2012, Sep-15, Volume: 186, Issue:6 Topics: Adult; Aged; Amikacin; Antibiotics, Antitubercular; Area Under Curve; Clarithromycin; Cohort Studies; Colorado; Drug Interactions; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial; Retrospective Studies; Rifabutin; Rifampin	2012
Familial cases of psittacosis: possible person-to-person transmission. Internal medicine (Tokyo, Japan), 2002, Volume: 41, Issue:7 Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Disease Transmission, Infectious; Female; Fluorescent Antibody Technique; Humans; Immunocompromised Host; Pneumonia, Bacterial; Primary Myelofibrosis; Psittacosis; Treatment Outcome	2002
Comparison of telithromycin, a new ketolide, with erythromycin and clarithromycin for the treatment of Haemophilus influenzae pneumonia in suckling, middle aged and senescent mice. International journal of antimicrobial agents, 2002, Volume: 20, Issue:3 Topics: Aging; Animals; Animals, Suckling; Anti-Bacterial Agents; Area Under Curve; Clarithromycin; Drug Administration Schedule; Drug Evaluation, Preclinical; Erythromycin; Haemophilus influenzae; Ketolides; Lung; Macrolides; Mice; Pneumonia, Bacterial; Tissue Distribution	2002
Antibiotic therapy for ambulatory patients with community-acquired pneumonia in an emergency department setting. Archives of internal medicine, 2003, Apr-14, Volume: 163, Issue:7 Topics: Adolescent; Adult; Aged; Alberta; Ambulatory Care; Analysis of Variance; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Community-Acquired Infections; Emergency Service, Hospital; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Treatment Outcome	2003
An economic evaluation of sequential i.v./po moxifloxacin therapy compared to i.v./po co-amoxiclav with or without clarithromycin in the treatment of community-acquired pneumonia. Chest, 2003, Volume: 124, Issue:2 Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Aza Compounds; Clarithromycin; Community-Acquired Infections; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Fluoroquinolones; France; Germany; Hospitalization; Humans; Injections, Intravenous; Male; Middle Aged; Moxifloxacin; Pneumonia, Bacterial; Quinolines; Randomized Controlled Trials as Topic	2003
Differential efficacy of clarithromycin in lung versus thigh infection models. Chemotherapy, 2004, Volume: 50, Issue:2 Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Female; Lung; Mice; Microbial Sensitivity Tests; Pneumonia, Bacterial; Streptococcal Infections; Streptococcus pneumoniae; Thigh	2004
Clarithromycin induced digoxin toxicity: case report and review. JPMA. The Journal of the Pakistan Medical Association, 2004, Volume: 54, Issue:8 Topics: Anti-Bacterial Agents; Anticoagulants; Atrial Fibrillation; Clarithromycin; Digoxin; Drug Interactions; Drug Therapy, Combination; Female; Humans; Middle Aged; Pneumonia, Bacterial; Warfarin	2004
Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2005, Volume: 24, Issue:3 Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Cefotaxime; Ceftriaxone; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Humans; Pneumonia, Bacterial	2005
An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care. Current medical research and opinion, 2005, Volume: 21, Issue:2 Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Community-Acquired Infections; Databases as Topic; Erythromycin; Female; Health Care Costs; Humans; Levofloxacin; Male; Managed Care Programs; Middle Aged; Models, Econometric; Ofloxacin; Pneumonia, Bacterial; Retrospective Studies; Risk Assessment; Treatment Outcome	2005
[A travel abroad-associated case of Legionella pneumonia diagnosed by urinary antigen detection test]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2005, Volume: 79, Issue:4 Topics: Aged; Anti-Bacterial Agents; Antigens, Bacterial; Clarithromycin; Drug Therapy, Combination; Fluoroquinolones; Humans; Immunologic Tests; Legionella pneumophila; Legionnaires' Disease; Male; Oxazines; Pneumonia, Bacterial; Travel; Turkey	2005
Pneumonia due to Mycobacterium abscessus in two domestic ferrets (Mustelo putorius furo). Australian veterinary journal, 2005, Volume: 83, Issue:9 Topics: Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Clarithromycin; Female; Ferrets; Mycobacterium; Mycobacterium Infections; Pneumonia, Bacterial; Treatment Outcome	2005
Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. American journal of respiratory and critical care medicine, 2006, Oct-15, Volume: 174, Issue:8 Topics: Aged; Anti-Infective Agents; Bacterial Proteins; Chaperonin 60; Chaperonins; Clarithromycin; Drug Resistance, Bacterial; Female; Humans; Macrolides; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial; Polymerase Chain Reaction; Prognosis; Retrospective Studies; RNA, Bacterial	2006
Delirium induced by clarithromycin in a patient with community-acquired pneumonia. The European respiratory journal, 2006, Volume: 28, Issue:3 Topics: Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Delirium; Female; Humans; Middle Aged; Pneumonia, Bacterial	2006
The expanding spectrum of Mycobacterium avium complex-associated pulmonary disease. Chest, 2006, Volume: 130, Issue:4 Topics: Adult; Amikacin; Biopsy; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Granuloma; Humans; Lung; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Necrosis; Pneumonia, Bacterial; Prednisone; Rifampin; Sputum; Tomography, X-Ray Computed	2006
[Coinfection with Mycoplasma pneumoniae and Chlamydophila pneumoniae in a middle-aged adult]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2007, Volume: 45, Issue:10 Topics: Anti-Bacterial Agents; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Humans; Male; Middle Aged; Mycoplasma pneumoniae; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Treatment Outcome	2007
A cost-effectiveness analysis of antimicrobial treatment of community-acquired pneumonia taking into account resistance in Belgium. Current medical research and opinion, 2008, Volume: 24, Issue:3 Topics: Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Belgium; Cefuroxime; Clarithromycin; Community-Acquired Infections; Cost-Benefit Analysis; Decision Support Techniques; Drug Costs; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Moxifloxacin; Pneumonia, Bacterial; Quinolines	2008
Infections due to Rhodococcus equi in three HIV-infected patients: microbiological findings and antibiotic susceptibility. International journal of clinical pharmacology research, 1994, Volume: 14, Issue:5-6 Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Bacteremia; Bronchoalveolar Lavage Fluid; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; HIV Infections; Humans; Imipenem; Male; Pleurisy; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Sputum; Teicoplanin; Vancomycin	1994
Clarithromycin-induced thrombocytopenic purpura. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 19, Issue:6 Topics: Aged; Clarithromycin; Community-Acquired Infections; Humans; Male; Pneumonia, Bacterial; Purpura, Thrombocytopenic	1994
[Isolation of Chlamydia pneumoniae in atypical pneumonia]. Deutsche medizinische Wochenschrift (1946), 1994, Oct-28, Volume: 119, Issue:43 Topics: Adult; Bronchoalveolar Lavage Fluid; Cefuroxime; Chlamydia Infections; Chlamydophila pneumoniae; Clarithromycin; DNA, Bacterial; Fluorescent Antibody Technique; Follow-Up Studies; Humans; Male; Pneumonia, Bacterial; Polymerase Chain Reaction; Recurrence	1994
Mycobacterium avium-intracellulare complex pneumonia in a non-HIV-infected individual: an increasingly recognized disease. Southern medical journal, 1996, Volume: 89, Issue:5 Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; HIV Seronegativity; Humans; Male; Mycobacterium avium-intracellulare Infection; Necrosis; Pneumonia, Bacterial; Pulmonary Atelectasis; Rifampin	1996
Rhodococcus or mycobacterium? An example of misdiagnosis in HIV infection. AIDS (London, England), 1997, Volume: 11, Issue:2 Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; Diagnostic Errors; Drug Therapy, Combination; Humans; Mycobacterium Infections; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Vancomycin	1997
Severe community-acquired pneumonia caused by atypical organisms. Acta clinica Belgica, 1997, Volume: 52, Issue:2 Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clarithromycin; Clavulanic Acids; Community-Acquired Infections; Critical Care; Diagnosis, Differential; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Humans; Male; Middle Aged; Netilmicin; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Psittacosis; Radiography; Treatment Failure	1997
[Pneumonia caused by Rhodococcus equi in patients with AIDS: difficulty in defining the most appropriate initial treatment]. Enfermedades infecciosas y microbiologia clinica, 1997, Volume: 15, Issue:5 Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Erythromycin; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Vancomycin	1997
Clarithromycin and azithromycin. The Pediatric infectious disease journal, 1998, Volume: 17, Issue:6 Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Humans; Otitis Media; Pneumonia, Bacterial; Soft Tissue Infections; Streptococcal Infections; Streptococcus pyogenes; Whooping Cough	1998
Neisseria meningitidis W135 pneumonia with sepicaemia in a nonogenarian. Scottish medical journal, 1998, Volume: 43, Issue:5 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Clarithromycin; Female; Humans; Meningococcal Infections; Neisseria meningitidis; Pneumonia, Bacterial; Serotyping; Sinusitis	1998
[The combination therapy of clarithromycin and sparfloxacin for pulmonary Mycobacterium gordonae infection]. Kekkaku : [Tuberculosis], 1999, Volume: 74, Issue:5 Topics: Aged; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pneumonia, Bacterial; Treatment Outcome	1999
In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 2000, Volume: 45, Issue:1 Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Mice; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Time Factors	2000
Oral absorption of clarithromycin in acute illness and during convalescence in patients with community-acquired pneumonia. Chest, 2000, Volume: 117, Issue:4 Topics: Absorption; Acute Disease; Administration, Oral; Aged; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Convalescence; Female; Humans; Male; Mouth Mucosa; Pneumonia, Bacterial; Prognosis; Prospective Studies; Radiography; Severity of Illness Index	2000
Treatment of Chlamydia pneumoniae. International journal of antimicrobial agents, 2000, Volume: 15, Issue:3 Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Antibodies, Bacterial; Azithromycin; Child; Child, Preschool; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Erythromycin; Humans; Pneumonia, Bacterial	2000
[A case of pneumonia caused by Mycobacterium avium complex successfully treated with clarithromycin]. Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 2000, Volume: 37, Issue:9 Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Female; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial	2000
[Pulmonary Mycobacterium gordonae infection treated with clarithromycin]. Kekkaku : [Tuberculosis], 2000, Volume: 75, Issue:12 Topics: Clarithromycin; Drug Resistance, Microbial; Female; Humans; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pneumonia, Bacterial; Treatment Outcome	2000
Chlamydia pneumoniae, clarithromycin, and severe asthma. Chest, 2001, Volume: 120, Issue:3 Topics: Anti-Bacterial Agents; Asthma; Chlamydophila pneumoniae; Chronic Disease; Clarithromycin; Humans; Pneumonia, Bacterial	2001
[Pneumonia caused by Nocardia nova]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2001, Volume: 39, Issue:7 Topics: Anti-Bacterial Agents; Clarithromycin; Diabetes Complications; Female; Humans; Middle Aged; Nocardia Infections; Opportunistic Infections; Pneumonia, Bacterial; Polymyositis; Treatment Outcome	2001
Surgery for Mycobacterium avium complex lung disease in the clarithromycin era. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2002, Volume: 21, Issue:2 Topics: Adult; Aged; Antibiotic Prophylaxis; Clarithromycin; Cohort Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonectomy; Pneumonia, Bacterial; Postoperative Complications; Preoperative Care; Retrospective Studies; Treatment Outcome	2002
[Soft-tissue abscess caused by Rhodococcus equi in a patient on hemodialysis]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2001, Volume: 21, Issue:6 Topics: Abscess; Actinomycetales Infections; Adrenal Cortex Hormones; Aged; Amikacin; Anti-Glomerular Basement Membrane Disease; Ciprofloxacin; Clarithromycin; Cyclophosphamide; Disease Susceptibility; Drug Therapy, Combination; Female; Humans; Imipenem; Immunocompromised Host; Immunosuppressive Agents; Kidney Failure, Chronic; Opportunistic Infections; Pneumonia, Bacterial; Renal Dialysis; Rhodococcus equi; Thigh	2001
Complicated nosocomial pneumonia due to Legionella pneumophila in an immunocompromised child. Scandinavian journal of infectious diseases, 2002, Volume: 34, Issue:3 Topics: Anti-Bacterial Agents; Child, Preschool; Ciprofloxacin; Clarithromycin; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Immunocompromised Host; Legionella pneumophila; Legionnaires' Disease; Male; Nutrition Disorders; Pneumonia, Bacterial	2002